Interventional Cardiology Devices Size, Share, Growth Analysis, By Product (Coronary Stents, Structural Heart Devices), By End User (Hospitals & ASCS, Catheterization Labs & Others), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35A2171 | Region: Global | Published Date: December, 2024
Pages: 242 |Tables: 67 |Figures: 65

Interventional Cardiology Devices Market Insights

Interventional Cardiology Devices Market size was valued at USD 13.85 Billion in 2023 and is poised to grow from USD 14.86 Billion in 2024 to USD 26.12 Billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).

Interventional cardiologists are trained cardiovascular disease specialists. They are primarily concerned with the use of catheters, which are thin, flexible tubes used to carry out procedures. Angioplasty, stenting, and other procedures are carried out by directing equipment through the arteries of the body. For many people, these minimally invasive interventional procedures are an acceptable option to open surgery. These devices are primarily used to treat heart problems. It employs a single type of catheter that is inserted into the body and is used to treat cardiovascular diseases. This occurs as a result of hypertension, diabetes, and cardiovascular disease. In addition, these devices are used to treat peripheral vascular problems that affect the circulatory system and can give rise to plaque build-up in limb arteries. Catheters, balloons, stents, and filters are examples of interventional cardiology devices available on the market. The advancement of more advanced and innovative cardiovascular devices, and also the ease with which regulatory licences can be obtained are driving the market growth. However, various government regulations and stringent approval criteria may also limit growth of the business.

US Interventional Cardiology Devices Market is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot - 2025-2032

Global Market Size

USD 13.1 billion

Largest Segment

Hospitals

Fastest Growth

Hospitals

Growth Rate

7.3% CAGR

Global Interventional Cardiology Devices Market, 2021-2028 ($ Bn)
Country Share for North America Region- 2021 (%)

To get more reports on the above market click here to Buy The Report

Interventional Cardiology Devices Market Segmental Analysis

Global Interventional Cardiology Devices Market is segmented by product, end user and region. Based on product, the market is segmented into coronary stents, structural heart devices, angioplasty balloons, catheters and embolic protection devices. Based on end user, the market is segmented into hospitals & ASCS and catheterization labs & others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Interventional Cardiology Devices Market Analysis by Product

Based on product, global interventional cardiology devices market is segmented into angioplasty stents, structural heart devices, catheters, angioplasty balloons, plaque modification devices, hemodynamic flow alteration devices, and others. The catheter segment is expected to lead the market during the forecast period followed by angioplasty stents, and angioplasty balloons, and it is also expected to grow at the fastest rate due to the increasing demand for minimally invasive surgery in the treatment of cardiovascular disease. Angiographic catheters, guiding catheters, and IVU/OCT catheters are all subdivided into this segment. Angiographic catheters account for the majority of the catheter market. Manufacturers are conducting extensive research and development in order to create new catheters that are functionally superior to their predecessors. The catheter segment is also growing due to the high prevalence of congenital and structural heart diseases.

Interventional Cardiology Devices Market Analysis by End-User

Based on end-user, global interventional cardiology devices market is segmented into ambulatory surgical centers, hospitals, and others. During the forecast period, hospitals are expected to lead the global market with the highest growth rate because advanced level instruments and treatment facilities are available with specialized consultants.

Global Interventional Cardiology Devices Market By End-user, 2021 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Interventional Cardiology Devices Market Regional Insights

North America is expected to lead the global interventional cardiology devices market throughout the forecast period due to the influence of advanced healthcare infrastructure, supportive government product development initiatives, and high patient awareness levels. According to the American Heart Association, by 2035, approximately 45% of the US population will be affected by heart disease as a result of factors such as high obesity, high smoking, and unhealthy lifestyles, which can cause a heart attack and other related issues. In addition, 1.5 million Americans are treated for diabetes each year in the United States alone. Incidence of diabetes is increasing primarily due to an increase in the geriatric population; it is guesstimated that 25% of all geriatric individuals (aged 60 and above) in the United States have diabetes.

Because of prevalence of overweight and changing lifestyle habits such as dietary irregularities, as well as an increasing number of global smokers, the United Kingdom in Europe is expected to hold the second-largest interventional cardiology devices market share.

Due to the increasing elderly and pediatric population, which is more likely to be exposed to coronary artery disease, Asia-Pacific is anticipated to emerge as the fastest growing region in the market during the forecast period. The convenience provided by these devices is driving Asia-Pacific market growth. Furthermore, increasing medical investment has contributed to the expansion of the regional market.

Global Interventional Cardiology Devices Market By Geography, 2021-2028
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Interventional Cardiology Devices Market Dynamics

Interventional Cardiology Devices Market Driver

  • Consumption of saturated fats, excessive salt, alcohol consumption, and smoking are all poor lifestyle practises that significantly raise the risk of coronary artery disease, which is expected to accelerate of the interventional cardiology devices market. Furthermore, high tobacco consumption and a lack of exercise motivate market growth. Furthermore, physical inactivity can increase the risk of obesity and coronary artery disease.

Interventional Cardiology Devices Market Restraint

  • To meet changing customer needs, the complicated regulatory standards for medical device affiliation are modified. These regulations are difficult because of the legal factors involved. Medical device performance and quality must be rigorously scrutinised in order to ensure public safety. As a result, the stringent and complex standards used to certify medical devices may limit market growth.

Request Free Customization of this report to help us to meet your business objectives.

Interventional Cardiology Devices Market Competitive Landscape

Global interventional cardiology devices market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D.

Interventional Cardiology Devices Market Top Player's Company Profiles

  • Abbott Laboratories 
  • B. Braun Melsungen AG 
  • Boston Scientific Corporation 
  • Medtronic PLC 
  • Terumo Corporation 
  • Biotronik SE & Co. KG 
  • Biosensors International Group Ltd 
  • ACIST Medical Systems 
  • Cardinal Health, Inc. 
  • Cook Medical Inc. 
  • Koninklijke Philips N.V. 
  • Edwards Lifesciences Corporation 
  • Nano Therapeutics Pvt. Ltd. 
  • AngioDynamics, Inc. 
  • Inari Medical, Inc. 
  • Genetesis, Inc. 
  • OptiMed Medical Instruments GmbH 
  • Meril Life Sciences Pvt. Ltd. 
  • OrbusNeich Medical

Interventional Cardiology Devices Market Recent Developments

  • In November 2022, Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has announced the introduction of a full cardiology suite to expedite and improve patient access to new cardiovascular treatments.
  • In October 2022, Dozee, a healthcare startup that offers contactless remote patient monitoring, is planning to launch an AI-powered, simple-to-use ECG patch for CVD patients. Because the system is cloud-enabled, the physician can receive alerts and view the patient's live and continuous ECG from anywhere.

Interventional Cardiology Devices Key Market Trends

  • Obesity is increasing the prevalence of cardiovascular disease. Furthermore, the incidence of coronary artery disease has increased as a result of changing lifestyles characterised by smoking, heavy alcohol consumption, and inactivity. With the use of interventional cardiology instruments, cardiologists can perform treatments quickly and without causing complications.
  • One major trend in the market is the development of technology. The leading interventional cardiology device companies are investing heavily in transcatheter aortic valve replacement technology and are also acquiring numerous start-up companies.

Interventional Cardiology Devices Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.

According to our global interventional cardiology devices market analysis, the Asia Pacific region is expanding due to rising healthcare costs and a greater understanding of the affordability and practicality of cardiology medical devices. However, the availability of effective first-line treatments, high device costs, and stringent regulatory requirements may limit the market growth.

Report Metric Details
Market size value in 2023 USD 13.85 Billion
Market size value in 2032 USD 26.12 Billion
Growth Rate 7.3%
Base year 2024
Forecast period 2025-2032
Forecast Unit (Value) USD Billion
Segments covered
  • Product
    • Coronary Stents, Structural Heart Devices, Angioplasty Balloons, Catheters, Embolic Protection Devices
  • End-user
    • Hospitals & ASCS, Catheterization Labs & Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Abbott Laboratories 
  • B. Braun Melsungen AG 
  • Boston Scientific Corporation 
  • Medtronic PLC 
  • Terumo Corporation 
  • Biotronik SE & Co. KG 
  • Biosensors International Group Ltd 
  • ACIST Medical Systems 
  • Cardinal Health, Inc. 
  • Cook Medical Inc. 
  • Koninklijke Philips N.V. 
  • Edwards Lifesciences Corporation 
  • Nano Therapeutics Pvt. Ltd. 
  • AngioDynamics, Inc. 
  • Inari Medical, Inc. 
  • Genetesis, Inc. 
  • OptiMed Medical Instruments GmbH 
  • Meril Life Sciences Pvt. Ltd. 
  • OrbusNeich Medical
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Interventional Cardiology Devices Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Interventional Cardiology Devices Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Interventional Cardiology Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Interventional Cardiology Devices Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Interventional Cardiology Devices Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Interventional Cardiology Devices Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Interventional Cardiology Devices Market size was valued at USD 13.85 Billion in 2023 and is poised to grow from USD 14.86 Billion in 2024 to USD 26.12 Billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).

Global interventional cardiology devices market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Abbott Laboratories ', 'B. Braun Melsungen AG ', 'Boston Scientific Corporation ', 'Medtronic PLC ', 'Terumo Corporation ', 'Biotronik SE & Co. KG ', 'Biosensors International Group Ltd ', 'ACIST Medical Systems ', 'Cardinal Health, Inc. ', 'Cook Medical Inc. ', 'Koninklijke Philips N.V. ', 'Edwards Lifesciences Corporation ', 'Nano Therapeutics Pvt. Ltd. ', 'AngioDynamics, Inc. ', 'Inari Medical, Inc. ', 'Genetesis, Inc. ', 'OptiMed Medical Instruments GmbH ', 'Meril Life Sciences Pvt. Ltd. ', 'OrbusNeich Medical'

Consumption of saturated fats, excessive salt, alcohol consumption, and smoking are all poor lifestyle practises that significantly raise the risk of coronary artery disease, which is expected to accelerate of the interventional cardiology devices market. Furthermore, high tobacco consumption and a lack of exercise motivate market growth. Furthermore, physical inactivity can increase the risk of obesity and coronary artery disease.

Obesity is increasing the prevalence of cardiovascular disease. Furthermore, the incidence of coronary artery disease has increased as a result of changing lifestyles characterised by smoking, heavy alcohol consumption, and inactivity. With the use of interventional cardiology instruments, cardiologists can perform treatments quickly and without causing complications.

North America is expected to lead the global interventional cardiology devices market throughout the forecast period due to the influence of advanced healthcare infrastructure, supportive government product development initiatives, and high patient awareness levels. According to the American Heart Association, by 2035, approximately 45% of the US population will be affected by heart disease as a result of factors such as high obesity, high smoking, and unhealthy lifestyles, which can cause a heart attack and other related issues. In addition, 1.5 million Americans are treated for diabetes each year in the United States alone. Incidence of diabetes is increasing primarily due to an increase in the geriatric population; it is guesstimated that 25% of all geriatric individuals (aged 60 and above) in the United States have diabetes.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Interventional Cardiology Devices Market

Report ID: SQMIG35A2171

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE